Onconova Therapeutics Inc
ONTX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$388.59K
Close$
$0.86
86.9% downside
Current Fair Value
86.9% downsideOvervalued by 86.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $388,589.00 |
|---|---|
| Enterprise Value | $-2,744,411.00 |
| Earnings per Share | $- |
| Beta | 2.87 |
| Outstanding Shares | - |
Return
| Return on Equity | -172469.20% |
|---|---|
| Return on Assets | 112307.98% |
| Return on Invested Capital | 405.27% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | -0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.98 |
| Enterprise Value to EBIT | 0.13 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
April 15, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%▲ 0.01% |
|---|---|
| Total Invested | $4 |
| Investors Holding | 1▲ 1.00% |
About Onconova Therapeutics Inc
CEO: Steven Fruchtman
